BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19320659)

  • 1. Is early onset breast cancer with no family history a good criterion for testing BRCA1 and BRCA2 genes? A small population-based study.
    Beristain E; Martínez-Bouzas C; Mallabiabarrena G; Tejada MI
    Clin Genet; 2009 Jun; 75(6):576-8. PubMed ID: 19320659
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
    Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H
    Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
    Fuller S; Liebens F; Carly B; Pastijn A; Rozenberg S
    Breast J; 2008; 14(6):603-4. PubMed ID: 19054005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].
    Meng J; Shi YR; Niu RF; Fu L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):79-82. PubMed ID: 19489266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Pregnancies, breastfeeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
    Huiart L; Sylvestre MP
    J Natl Cancer Inst; 2007 Jul; 99(14):1130-1; author reply 1131. PubMed ID: 17623800
    [No Abstract]   [Full Text] [Related]  

  • 7. How reliable are BRCA1/2 mutation estimates?
    McClain MR; Palomaki GE; Haddow JE
    Cancer Res; 2007 May; 67(10):5057; author reply 5057-8. PubMed ID: 17510441
    [No Abstract]   [Full Text] [Related]  

  • 8. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
    Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACLU lawsuit questions the patenting of breast cancer genes.
    Printz C
    Cancer; 2009 Nov; 115(21):4887-8. PubMed ID: 19842208
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer: early diagnosis.
    Othieno-Abinya NA
    East Afr Med J; 2000 Jun; 77(6):289-90. PubMed ID: 12858924
    [No Abstract]   [Full Text] [Related]  

  • 12. Family physicians and referrals of low-risk women for BRCA1/2 genetic services.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(2):70-2. PubMed ID: 19258448
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic services have value beyond BRCA1/2 testing.
    Hall MJ
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):686. PubMed ID: 19208665
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishing a family risk assessment clinic for breast cancer.
    Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
    Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It's not for me... it's for my daughter.
    Eisinger F
    Eur J Cancer; 2007 Jan; 43(2):226-7. PubMed ID: 17046238
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights from the Louisville breast cancer update. An update on the management of high-risk breast cancer and preinvasive disease.
    Chagpar AB
    J Ky Med Assoc; 2008 Nov; 106(11):537-8. PubMed ID: 19058480
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology.
    Roukos DH
    Ann Surg; 2009 Jun; 249(6):1067-8. PubMed ID: 19474669
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring DNA repair capacity: small steps.
    Berwick M; Vineis P
    J Natl Cancer Inst; 2005 Jan; 97(2):84-5. PubMed ID: 15657333
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.